Skip to content
Clinical Trials – home
SwedenBack to Sweden

Clinical trials in Ystad – page 13

317 clinical trials in Ystad, Sweden. Every trial is listed in the EU Clinical Trials Register and updated daily.

SwedenOur site in SwedenKliniska-Provningar.se(opens in a new tab)
Ystad at a glance
317
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

317 trials in Ystad

Open in trial search

Study on Tioguanine and Drug Combination for Patients Aged 0-45 with Newly Diagnosed Acute Lymphoblastic Leukemia

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:0–17 years · 18–64 years
  • Substances:Blinatumomab
  • Sponsor:Karolinska University Hospital

Study on Personalized vs Non-Personalized Radionuclide Therapy with 177Lu-Edotreotide and Capecitabine for Patients with Neuroendocrine Tumors

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Region Skane

Endocarditis

Recruiting

Study on Shortened Antibiotic Treatment for Infectious Endocarditis Using Vancomycin, Meropenem, and Ceftriaxone for Patients with Left-Sided Heart Infection

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Ampicillin
  • Sponsor:Region Skane

Acute leukaemia+6

Recruiting

Study on Triptorelin for Fertility Protection in Young Women and Teenagers Undergoing Chemotherapy for Breast Cancer, Leukemia, Lymphomas, and Sarcomas

Registered drug
Countries:SwedenSweden
  • Participants:0–17 years · 18–64 years
  • Substances:Triptorelin
  • Sponsor:Karolinska University Hospital

Depression

Recruiting

Study on Adding OSU6162 to Treatment for Patients with Depression Resistant to SSRI/SNRI Medications

Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Placebo
  • Sponsor:University Of Gothenburg

Study of Pivmecillinam and Amoxicillin/Clavulanic Acid for Treating Urinary Tract Infections in Patients with Multidrug-Resistant Bacteria

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Amoxicillin
  • Sponsor:Region Skane

Atrial fibrillation

Not yet recruiting

Prevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Regeneron Pharmaceuticals Inc.

Non-small cell lung cancer

Not yet recruiting

Phase II Randomized Trial of Adjuvant Durvalumab Immunotherapy After Neoadjuvant Chemoimmunotherapy in Patients With Resectable Non‑Small Cell Lung Cancer

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Oslo University Hospital HF

Pulmonary embolism

Not yet recruiting

Reduced-dose versus full-dose alteplase for high-risk acute pulmonary embolism patients: a randomized multicenter trial

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Alteplase
  • Sponsor:University Of Gothenburg
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:AZD0120
  • Sponsor:AstraZeneca AB

Durvalumab after chemoradiation for patients with limited‑stage small cell lung cancer: a randomized trial of high‑dose versus standard thoracic radiation

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Norwegian University Of Science And Technolology

Malignant melanoma stage IV+1

Not yet recruiting

Phase Ib/II study of momelotinib with nivolumab or pembrolizumab in unresectable stage III/IV cutaneous melanoma

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Momelotinib
  • Sponsor:Karolinska University Hospital

Other cities in Sweden

The busiest research cities in the country

All 66 cities in Sweden

Clinical research in Ystad

What the registry says about research in the country

01 Cardiovascular and Emergency Medicine

Innovative research investigating early vasopressor therapy for patients presenting with hypotension in emergency departments. This study aims to improve shock control protocols and potentially reduce intensive care unit admissions.

  • Shock Management
  • Emergency Care Protocols
  • Hemodynamic Support

The research focuses on comparing noradrenaline-based intervention versus traditional fluid therapy approaches.

02 Oncology Research

Studies exploring novel approaches in colorectal cancer treatment, particularly focusing on patients with specific genetic mutations in the PI3K signaling pathway. The research evaluates the potential benefits of acetylsalicylic acid in preventing cancer recurrence.

  • Targeted Cancer Therapy
  • Genetic Mutation Analysis
  • Cancer Prevention

This trial represents a significant step in personalized medicine for colorectal cancer treatment.

03 Nephrology and Cardiology

Clinical investigation examining stroke prevention in patients with chronic kidney disease and atrial fibrillation. The research evaluates the safety and efficacy of anticoagulation therapy in this complex patient population.

  • Stroke Prevention
  • Renal Disease Management
  • Anticoagulation Safety

This study addresses a critical gap in treatment protocols for patients with concurrent kidney and heart conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.